ClinicalTrials.Veeva

Menu
A

Austin Heart | Austin Heart Central at the Heart Hospital of Austin

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PB127
Aspirin
Bococizumab
Ziltivekimab
A-002
aspirin
Clopidogrel
DAPT
losartan
BO-653

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

17 of 66 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects wi...

Active, not recruiting
Aortic Stenosis
Device: Medtronic CoreValve TAVR System
Device: Edwards SAPIEN 3 TAVR System

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneousl...

Invitation-only
Heart Failure
Other: Sham-Control
Device: Alleviant ALV1 System

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Enrolling
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Ziltivekimab
Drug: Placebo

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure...

Enrolling
Heart Failure with Moderately Reduced Ejection Fraction
Diastolic Heart Failure
Device: OPTIMIZER™ Smart Mini System
Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System

The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered...

Active, not recruiting
Heart Failure
Device: BATwire Implant Kit

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling
Heart Failure with Reduced Ejection Fraction (HFrEF)
Dilated Cardiomyopathy
Device: AccuCinch Ventricular Restoration System
Drug: Guideline-Directed Medical Therapy

Evaluation of initial safety and clinical feasibility of the Hēlo PE Thrombectomy System for thrombectomy in acute submassive pulmonary embolism (PE).

Enrolling
Pulmonary Embolism
Device: Hēlo PE Thombectomy System

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients wi...

Enrolling
Mitral Valve Regurgitation
Device: MitraClip™ device implantation
Procedure: Mitral Valve Repair Surgery

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic...

Enrolling
Aortic Stenosis, Severe
Aortic Stenosis
Device: Edwards SAPIEN 3/SAPIEN 3 Ultra THV

To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis w...

Active, not recruiting
Aortic Stenosis
Procedure: SAVR
Device: SAPIEN 3 THV

This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System...

Active, not recruiting
Heart Failure NYHA Class III
Device: Cordella™ Pulmonary Artery Sensor System

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Arte...

Enrolling
Heart Failure NYHA Class II
Heart Failure NYHA Class III
Device: Cordella™ Pulmonary Artery Sensor System

The objective of the RELIEVE-HF study is to provide reasonable assurance of safety and effectiveness of the V-Wave Interatrial Shunt System by improv...

Active, not recruiting
Heart Failure
Other: Control
Device: V-Wave Interatrial Shunt

This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Si...

Active, not recruiting
Cardiac Disease
Right Heart Failure
Device: CorVista Capture

This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) fo...

Enrolling
Mitral Valve Insufficiency
Mitral Regurgitation
Device: SAPIEN M3 valve and dock

The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomati...

Active, not recruiting
Tricuspid Regurgitation
Device: TriClipTM Device

Trial sponsors

Abbott logo
Edwards Lifesciences logo
P
A
A
Anthera Pharmaceuticals logo
AtriCure logo
C
E
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems